- Seattle, Washington
- The leader in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors.
- Chad Robins, Harlan Robins, Christopher Carlson
- Therapeutics, Health Care, Biotechnology
Adaptive Biotechnologies is the pioneer and leader in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors.
We bring the accuracy and sensitivity of our immunosequencing platform into laboratories around the world to drive groundbreaking research in cancer and other immune-mediated diseases. We are also committed to translating immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care.
Funding Rounds (5) - $396.5MUpdate
Current Team (11)Update
329 Oyster Point Blvd., Ste 100
South San Francisco, California 94080
Corporate Headquarters / Research
1551 Eastlake Ave E
Seattle, Washington 98102